B WAIVERS: A YEAR IN REVIEW MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER,

Slides:



Advertisements
Similar presentations
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
Advertisements

Medical Exams for U.S. Bound Refugees
Health Assessment Abnormal Cases. Objective Review Health Assessment Status transitions for abnormal cases Record HA (Health Assessment) Results for an.
Quality Assurance Challenges Associated with Decentralizing the Entry of Tuberculosis Surveillance Data TB PEN Conference September 2011 Sandra P. Matus,
Ebola Facts October 28, /28/14 Identify, Isolate, Inform: ED Evaluation and Management The following diagram provides guidance on evaluation and.
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Group Processing and Client Centered Approach Joy Baldwin Manager Interim Federal Health Medical Services Branch Citizenship and Immigration Canada Vancouver,
Module 2 - Epidemiology of Tuberculosis
World Health Organization TB Case Definitions
Invasive Group A Strep Infections Associated With Bath Salts Injection Patty Carson, BA, SM (ASCP) 1,2, Sara Robinson, MPH 1, Stephen Sears, MD, MPH 1.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Deepthi Rajeev, MS, MSc Department of Biomedical Informatics University of Utah Evaluating the Impact of Electronic Disease Surveillance Systems On Local.
TB Outbreak in Grand Forks
FORMS FOR THE FUTURE CTBCP Annual Meeting March 20, 2014 Maryland Department of Health and Mental Hygiene Prevention and Health Promotion Administration.
The Public Health Applications of Molecular Epidemiology: Use of HIV-1 Pol Sequences to Identify HIV Transmission Networks in Los Angeles County Jennifer.
Health Care and Immigrant Populations in the U.S. James A. Litch MD, DTMH Centers for Disease Control and Prevention; WA Department of Health, Epidemiology.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
West Virginia’s Tuberculosis Control Program Hx and Epi MissionTransmissionRequirements Channels of Communication.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
New Tuberculosis Reports Melissa Ehman Epidemiologist California TB Controllers Association Meeting October 22, 2010.
Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
World Refugee Day June 20, 2014 “He who has health, has hope. And he who has hope, has everything.” ~ Arabian Proverb.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Current Trends in Refugee Health DHMH TB Annual Meeting March 20, 2014 Dipti D. Shah, MPH Chief, Office of Immigrant Health Maryland Department of Health.
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
Epidemiology Tools and Methods Session 2, Part 1.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
Tuberculosis Treatment Completion Among Persons Incarcerated at Diagnosis, U.S. TB Surveillance System, 1999–2008 Kiren Mitruka, MD, MPH (presented on.
LESSON 9.5: TYPES OF STUDIES Module 9: Epidemiology Obj. 9.5: Compare & contrast different types of epidemiological studies.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Introduction to Tuberculosis Genotyping National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Improving Initial Evaluation for Persons with Class A/B TB Conditions Massachusetts Department of Public Health, Bureau of Infectious Disease Division.
TEMPLATE DESIGN © Increasing treatment completion of LTBI in high-risk international university students A. Anderson RN.
1 COMMUNITY DENTAL HEALTH Algonquin College Janet Ladas.
Learning Well Evaluation Academic Year Indiana University Bowen Research Center Terrell W. Zollinger, DrPH Robert M. Saywell, Jr., PhD, MPH Jennifer.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
More information © 2015 Denver Public Health Michelle K Haas, Kaylynn Aiona, Pete Dupree, Ellen Brilliant, Robert Belknap Improving access to Tuberculosis.
T T H H I I Tennessee Health Indicators PROGRAM DIRECTOR: DR. JON WARKENTIN DATA DIRECTOR/EPIDEMIOLOGIST: JASON CUMMINS, MPH Tuberculosis Elimination Program.
Post-arrival TB Screening of the High-Risk Refugees and Immigrants in Maryland Natasha Chida, MD MSPH Baltimore City Health Department March 22 nd, 2016.
Prevalence of Pulmonary Tuberculosis among the Somali Population in Minnesota Sahur Hussein, Sponsers; Dr. Blinnikov, Mikhail; Antunez, Hector Giovanni.
Mumps Outbreaks Associated with Correctional Facilities Texas
National Tuberculosis Genotyping Service
TB Genotyping and Whole Genome Sequencing in California
Whole-Genome Sequencing; It’s Not Just For Epis
Continuum of Surveillance Updates from Epidemiological Services New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) Annual.
Point Prevalence Survey in a Long Term Care Facility, 2016
This is an archived document.
Vibrio parahaemolyticus in Virginia
Improved Latent Tuberculosis Therapy Completion Rates in Refugee Patients Through Use of a Clinical Pharmacist Kimberly L. Carter, Pharm.D., BCACP Assistant.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Building sustainable partnerships with health centers to improve HIV prevention and care capacity: A New York State quality of care model Rachel Hart-Malloy,
Sarah Siddiqui, MD, MPH University of Texas Medical Branch
Mark Lobato, MD Division of TB Elimination
Luigi Naldi  Journal of Investigative Dermatology 
Texas Framework For Heart Disease and Stroke Improved Quality of Life
Using Whole Genome Sequencing Analysis in California
Needs Assessment for Gypsy Americans Ashley Haynes, Savannah Patton, Kyle Marshall Department of Health Education and Health Promotion Introduction Findings.
Laura Lane, Epidemiologist
Varicella Vaccine Efficacy Estimates
Lab Results + RVCT Notification=
Surveillance: From Patient to CDC
Presentation transcript:

B WAIVERS: A YEAR IN REVIEW MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER, MA EPIDEMIOLOGIST CENTER FOR TB CONTROL & PREVENTION

What is a B Waiver? Overseas pre-screening medical evaluation before entry to the U.S. which assesses health status Waivers are assigned to individuals with TB conditions  B1 – No treatment  B1 – Treatment completed  B2 – LTBI Evaluation

Total Arrivals, Immigrants, Refugees & Asylees488373

Total Arrivals by Status,

Diagnoses: Overview of Classes Class 0: No TB exposure, no evidence of infection Class 1: TB exposure, no evidence of infection Class 2: Latent TB infection Class 3: Active disease Class 4: TB, inactive disease

Diagnoses: The Numbers Outcome Arrived (all waivers) Not Evaluated7860 Evaluation Pending677 Evaluated / Have Diagnosis 404 (83%) 236 (63%) Class 0/1 (No TB) Class 2 (LTBI)16774 Class 3 (Active TB)31 Class 4 (“Inactive” TB)8052

Class 2 (LTBI) Arrivals by Status, Immigrant 104 (62%) 57 (77%) Refugee 55 (33%) 13 (18%) Asylee8 (5%)4 (5%)

TB Risk Assessment: Top Countries of Examination, 2012 Country # of Arrivals in 2012 TB Case Rate 2012 (cases per 100,000) Philippines Nepal Malaysia China Maryland (2012 data) 3.0

Class 2 (LTBI) by County of Origin Country of Examination Philippines5234 Nepal336 Malaysia157 China103

GENOTYPING SUMMARY 2013 MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER, MA EPIDEMIOLOGIST CENTER FOR TB CONTROL & PREVENTION

Background Information Genotyping is performed on all culture positive specimens in Maryland Results are reported out through a CDC national system, TB GIMS Isolates in GIMS are linked to the RVCT record Reports in GIMS can be run on a given single isolate or cluster

Genotyping Coverage and Clustering 2012 Of 161 culture positive patients in Maryland in 2012, 160 (99.4%) had an isolate sent for genotyping.  CDC national target = 94% coverage  How do we stack up nationally? Of 160 genotyped isolates, 71 (44%) were given a cluster number  Some were clustered with others in same year, some dated back 4+ years  Not all clusters contain known epidemiologic links or are due to recent transmission

Examples of Uses of Genotyping in 2013 Lab contamination/false positive investigations Cohort Review sessions Cluster investigations Identifying rarity of patterns

Questions? Think of something later?  –  Office –